December 28, 2025 10:01 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
CBI moves Supreme Court challenging Kuldeep Sengar's relief in Unnao rape case | Music under attack: Islamist mob attacks James concert with bricks, stones in Bangladesh, dozens hurt | Christmas vandalism sparks mass arrests in Raipur; Assam acts too with crackdown on 'religious intolerance' | BJP's VV Rajesh becomes Thiruvananthapuram Mayor after party topples Left's 45-year-rule in city corporation | ‘I can’t bear the pain’: Indian-origin father of three dies after 8-hour hospital wait in Canada hospital | Janhvi Kapoor, Kajal Aggarwal, Jaya Prada slam brutal lynching in Bangladesh, call out ‘selective outrage’ | Tarique Rahman returns to Bangladesh after 17 years | Shocking killing inside AMU campus: teacher shot dead during evening walk | Horror on Karnataka highway: sleeper bus bursts into flames after truck crash, 9 killed | PM Modi attends Christmas service at Delhi church, sends message of love and compassion
Pfizer
Image: Wikimedia Commons

Pfizer launches pilot COVID-19 vaccine distribution preparedness program in 4 US states

| @indiablooms | Nov 17, 2020, at 10:14 pm

Moscow/Sputnik: US pharmaceutical company Pfizer announced in a press release on Tuesday it was launching a pilot program that aims to inform the delivery and distribution of its coronavirus vaccine in the US states of Rhode Island, Texas, New Mexico and Tennessee.

"To build on our coordination with the relevant U.S. agencies, Pfizer launched this pilot program to help better support the states’ planning, deployment, and administration of the COVID-19 vaccine candidate. Learnings from this program will be adapted for usage across other states to help them create effective immunization programs for this vaccine," the company said in a press release.

According to Pfizer, the four US states were selected due to their differences in overall size, diversity of populations, and immunization infrastructure, as well as the need to reach populations both in rural and urban areas.

In a disclaimer of future preferential benefits for these four states, the company has stressed that they "will not receive vaccine doses earlier than other states by virtue of this pilot, nor will they receive any differential consideration."

Pfizer developed the vaccine in collaboration with German biotechnology company BioNTech. As the unregistered vaccine is underway with phase 3 clinical trials, the creators have declared above 90-percent efficiency.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.